Talimogene Laherparepvec plus Pembrolizumab Is Effective in Sarcomas

Article navigation

Research Watch| March 03 2020

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2020) 10 (3): 340.

Abstract

Pembrolizumab with the oncolytic virus talimogene laherparepvec was effective in treating sarcomas.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.